Giulio Pompilio

Associate Professor of Cardiac Surgery

University of Milan
Country flagItaly

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Giulio Pompilio is an Associate Professor of Cardiac Surgery at the University of Milan, Italy. His research areas include coronary bypass surgery, cardiac regeneration, and the impact of antihypertensive drugs on brain function. He has published recent articles examining topics such as arrhythmogenic cardiomyopathy, myocardial regeneration, and the therapeutic effects of various treatments on heart conditions.

Articles (12)

Background and Aims In patients with three-vessel disease and/or left main disease, selecting revascularization strategy based on coronary computed tomography angiography (CCTA) has a high level of virtual agreement with treatment decisions based on invasive coronary angiography (ICA). Methods In this study, coronary artery bypass grafting (CABG) procedures were planned based on CCTA without knowledge of ICA. The CABG strategy was recommended by a central core laboratory assessing the anatomy and functionality of the coronary circulation. The primary feasibility endpoint was the percentage of operations performed without access to the ICA. The primary safety endpoint was graft patency on 30-day follow-up CCTA. Secondary endpoints included topographical adequacy of grafting, major adverse cardiac and cerebrovascular (MACCE), and major bleeding events at 30 days. The study was considered positive if the lower boundary of confidence intervals (CI) for feasibility was ≥75% (NCT04142021). Results The study enrolled 114 patients with a mean (standard deviation) anatomical SYNTAX score and Society of Thoracic Surgery score of 43.6 (15.3) and 0.81 (0.63), respectively. Unblinding ICA was required in one case yielding a feasibility of 99.1% (95% CI 95.2%–100%). The concordance and agreement in revascularization planning between the ICA- and CCTA-Heart Teams was 82.9% with a moderate kappa of 0.58 (95% CI 0.50–0.66) and between the CCTA-Heart Team and actual treatment was 83.7% with a substantial kappa of 0.61 (95% CI 0.53–0.68). The 30-day follow-up CCTA in 102 patients (91.9%) showed an anastomosis patency rate of 92.6%, whilst MACCE was 7.2% and major bleeding 2.7%. Conclusions CABG guided by CCTA is feasible and has an acceptable safety profile in a selected population of complex coronary artery disease.

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (10)

Maila Chirivì

-

ITALY
View details

Michela Casella

-

ITALY
View details

Scot Garg

Professor Cardiology

University of Central Lancashire

UNITED KINGDOM
View details

Johan de Mey

Vrije Universiteit Brussel

BELGIUM
View details

Stefan Janssens

University Hospitals Leuven

BELGIUM
View details

Patrick W. Serruys

Prof. of Cardiology

Imperial College London

UNITED KINGDOM
View details

Marco Pozzi

Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea

ITALY
View details

Chiara Vantaggiato

Istituto di Ricovero e Cura a Carattere Scientifico Eugenio Medea

ITALY
View details

Yoshinobu Onuma

University of Galway

IRELAND
View details

Dario Cattaneo

University Hospital

ITALY
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.